These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 28625004)

  • 1. Distribution-Weighted Cost-Effectiveness Analysis Using Lifetime Health Loss.
    Hernæs UJV; Johansson KA; Ottersen T; Norheim OF
    Pharmacoeconomics; 2017 Sep; 35(9):965-974. PubMed ID: 28625004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes on oral anti-diabetes drugs: cost-effectiveness in France, Germany, Italy, and Spain.
    Tunis SL; Willis WD; Foos V
    Curr Med Res Opin; 2010 Jan; 26(1):163-75. PubMed ID: 19919377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the role of cost-effectiveness thresholds in healthcare priority setting.
    Siverskog J; Henriksson M
    Int J Technol Assess Health Care; 2021 Jan; 37():e23. PubMed ID: 33491617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analyzing cost-effectiveness of ulnar and median nerve transfers to regain forearm flexion.
    Wali AR; Park CC; Brown JM; Mandeville R
    Neurosurg Focus; 2017 Mar; 42(3):E11. PubMed ID: 28245686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new proposal for priority setting in Norway: Open and fair.
    Ottersen T; Førde R; Kakad M; Kjellevold A; Melberg HO; Moen A; Ringard Å; Norheim OF
    Health Policy; 2016 Mar; 120(3):246-51. PubMed ID: 26851991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of high-dose versus standard-dose inactivated influenza vaccine in adults aged 65 years and older: an economic evaluation of data from a randomised controlled trial.
    Chit A; Becker DL; DiazGranados CA; Maschio M; Yau E; Drummond M
    Lancet Infect Dis; 2015 Dec; 15(12):1459-66. PubMed ID: 26362172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary vs secondary prophylaxis with pegfilgrastim for the reduction of febrile neutropenia risk in patients receiving chemotherapy for non-Hodgkin's lymphoma: cost-effectiveness analyses.
    Hill G; Barron R; Fust K; Skornicki ME; Taylor DC; Weinstein MC; Lyman GH
    J Med Econ; 2014 Jan; 17(1):32-42. PubMed ID: 24028444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Cost-effectiveness of Statin Treatment for Primary Prevention of Cardiovascular Disease in the Elderly.
    Lin L; Teng M; Zhao YJ; Khoo AL; Seet RC; Yong QW; Yeo TC; Lim BP
    Cardiovasc Drugs Ther; 2015 Apr; 29(2):187-97. PubMed ID: 25860556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corneal Collagen Cross-Linking in the Management of Keratoconus in Canada: A Cost-Effectiveness Analysis.
    Leung VC; Pechlivanoglou P; Chew HF; Hatch W
    Ophthalmology; 2017 Aug; 124(8):1108-1119. PubMed ID: 28457614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of laparoscopic gastric banding and bypass for morbid obesity.
    Campbell J; McGarry LA; Shikora SA; Hale BC; Lee JT; Weinstein MC
    Am J Manag Care; 2010 Jul; 16(7):e174-87. PubMed ID: 20645663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the cost-effectiveness of treating chronic hepatitis C virus in people who inject drugs in Australia.
    Visconti AJ; Doyle JS; Weir A; Shiell AM; Hellard ME
    J Gastroenterol Hepatol; 2013 Apr; 28(4):707-16. PubMed ID: 23173753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verteporfin photodynamic therapy cohort study: report 3: cost effectiveness and lessons for future evaluations.
    Grieve R; Guerriero C; Walker J; Tomlin K; Langham J; Harding S; Chakravathy U; Carpenter J; Reeves BC;
    Ophthalmology; 2009 Dec; 116(12):2471-77.e1-2. PubMed ID: 19948278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative outcomes and cost-utility following surgical treatment of focal lumbar spinal stenosis compared with osteoarthritis of the hip or knee: part 2--estimated lifetime incremental cost-utility ratios.
    Rampersaud YR; Tso P; Walker KR; Lewis SJ; Davey JR; Mahomed NN; Coyte PC
    Spine J; 2014 Feb; 14(2):244-54. PubMed ID: 24239803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of DTG + ABC/3TC versus EFV/TDF/FTC for first-line treatment of HIV-1 in the United States.
    Peng S; Tafazzoli A; Dorman E; Rosenblatt L; Villasis-Keever A; Sorensen S
    J Med Econ; 2015; 18(10):763-76. PubMed ID: 25934146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconciliation of economic concerns and health policy: illustration of an equity adjustment procedure using proportional shortfall.
    Stolk EA; van Donselaar G; Brouwer WB; Busschbach JJ
    Pharmacoeconomics; 2004; 22(17):1097-107. PubMed ID: 15612829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Making use of equity sensitive QALYs: a case study on identifying the worse off across diseases.
    Lindemark F; Norheim OF; Johansson KA
    Cost Eff Resour Alloc; 2014; 12():16. PubMed ID: 25089121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness of Endovascular Stroke Therapy: A Patient Subgroup Analysis From a US Healthcare Perspective.
    Kunz WG; Hunink MG; Sommer WH; Beyer SE; Meinel FG; Dorn F; Wirth S; Reiser MF; Ertl-Wagner B; Thierfelder KM
    Stroke; 2016 Nov; 47(11):2797-2804. PubMed ID: 27758942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifetime QALY prioritarianism in priority setting: quantification of the inherent trade-off.
    Ottersen T; Mæstad O; Norheim OF
    Cost Eff Resour Alloc; 2014 Jan; 12(1):2. PubMed ID: 24418267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do Quality-Adjusted Life Years Discriminate Against the Elderly? An Empirical Analysis of Published Cost-Effectiveness Analyses.
    Xie F; Zhou T; Humphries B; Neumann PJ
    Value Health; 2024 Jun; 27(6):706-712. PubMed ID: 38548176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.